Imagine trying to stop a long-term habit, but the instructions are vague and the risks are high. This project creates a clear, step-by-step guide for doctors and patients to safely stop using sleeping pills and anxiety meds in seniors. It's like a GPS for weaning off medication to avoid dangerous side effects and lower healthcare costs.
Older adults are over-prescribed sedative-hypnotics, leading to high healthcare costs and dangerous side effects. Current efforts to reduce this use lack a standardized, patient-centered method for large-scale implementation.
A toolkit containing clinical guidelines, implementation recommendations, patient-centred self-management materials, and inter-sectoral clinical pathways.
If you are a health-tech app developer dealing with low patient adherence to medication changes — this project developed patient-centred materials and guidelines that improve self-management for seniors. This allows for the creation of evidence-based digital weaning tools.
If you are a clinical pathway consultancy dealing with inefficient medication reviews in nursing homes — this project developed inter-sectoral clinical pathways and logic models. These tools help standardize the process of reducing harmful drug use across different healthcare systems.
If you are a private clinic network dealing with high costs and adverse events related to sedative overuse — this project developed a toolkit to implement best practices in a standardized way. This reduces the financial and medical risks associated with BSH overuse in older patients.
Based on available project data, there is no specific pricing mentioned for the toolkit; however, the project received an EU contribution of EUR 4,883,229 to develop these resources.
Yes, the project specifically develops logic models and a toolkit designed to facilitate the scale-up and spread of the intervention across diverse European healthcare systems.
Based on available project data, specific IP or licensing terms are not provided, though the project follows a governance structure to ensure legal compliance across 7 countries.
The project adapts inter-sectoral clinical pathways and provides a toolkit that allows healthcare systems to implement the process in a standardized way while accounting for local context.
The project period runs from 2022-09-01 to 2027-08-31, indicating that the final validated toolkit will be available toward the end of this window.
The consortium is heavily academic, with 5 universities and 1 research entity, but it maintains a practical edge with 1 industry partner and 2 SMEs. With 10 partners across 7 countries, the group has the geographic reach to validate clinical pathways across different regulatory environments, though the 10% industry ratio suggests the primary output is clinical evidence rather than a commercial product.
Contact the Universite Catholique de Louvain in Belgium
Contact us to explore licensing opportunities for the BSH reduction toolkit.
